World Cancer Report, 2020 (https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020)
Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstetrics. 2019;145(1):129–35.
Thelissen AAB, Jürgenliemk-Schulz IM, van der Leij F, Peters M, Gerestein CG, Zweemer RP, van Rossum PSN. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2022;164(3):667–74.
Tian Y, Luo H. Diagnostic accuracy of transvaginal ultrasound examination for local staging of cervical cancer: a systematic review and meta-analysis. Med Ultrason. 2022;24(3):348–55.
Charakorn C, Thadanipon K, Chaijindaratana S, Rattanasiri S, Numthavaj P, Thakkinstian A. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: a systematic review and meta-analysis. Gynecol Oncol. 2018;150(1):190–200.
Article CAS PubMed Google Scholar
Harima Y, Ariga T. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: a multicenter prospective cohort study. PLoS ONE. 2021;16(11): e0259235.
Article CAS PubMed PubMed Central Google Scholar
Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB. Can initial serum cyfra 21–1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecol Oncol. 2000;77(1):164–70.
Article CAS PubMed Google Scholar
Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics. 2005;5(13):3262–77.
Article CAS PubMed Google Scholar
Nie L, Xin S, Zheng J, Luo Y, Zou Y, Liu X, Chen H, Lei X, Zeng X, Lai H. DIA-based proteomics analysis of serum-derived exosomal proteins as potential candidate biomarkers for intrahepatic cholestasis in pregnancy. Archives of Gynecol Obstet. 2022;308:79–89.
Cao XL, Song JY, Sun ZG. Quantitative label-free proteomic analysis of human follicle fluid to identify novel candidate protein biomarker for endometriosis-associated infertility. J Proteomics. 2022;266: 104680.
Article CAS PubMed Google Scholar
Olthof EP, van der Aa MA, Adam JA, Stalpers LJA, Wenzel HHB, van der Velden J, Mom CH. The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review. Int J Clin Oncol. 2021;26(9):1600–10.
Liao Y, Huang J, Liu P, Zhang C, Liu J, Xia M, Shang C, Ooi S, Chen Y, Qin S, et al. Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer. Oncogene. 2022;41(13):1931–43.
Article CAS PubMed PubMed Central Google Scholar
Shi S, Ma HY, Zhang ZG. Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer: A meta and bioinformatics analysis. Pathol Res Pract. 2021;227: 153624.
Article CAS PubMed Google Scholar
Heeren AM, Koster BD, Samuels S, Ferns DM, Chondronasiou D, Kenter GG, Jordanova ES, de Gruijl TD. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer. Cancer Immunol Res. 2015;3(1):48–58.
Article CAS PubMed Google Scholar
Wenzel HHB, Van Kol KGG, Nijman HW, Lemmens V, Van der Aa MA, Ebisch RMF, Bekkers RLM. Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI? Gynecol Oncol. 2020;158(2):282–6.
Du Q, Liu P, Zhang C, Liu T, Wang W, Shang C, Wu J, Liao Y, Chen Y, Huang J, et al. FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis. Cell Death Dis. 2022;13(5):488.
Article CAS PubMed PubMed Central Google Scholar
Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, Qin S, He S, Yao S, Wang W. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics. 2020;10(15):6561–80.
Article CAS PubMed PubMed Central Google Scholar
Cheng Y, Chen G, Hong L, Zhou L, Hu M, Li B, Huang J, Xia L, Li C. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer? Ann Diagn Pathol. 2013;17(3):305–11.
Chaudary N, Mujcic H, Wouters BG, Hill RP. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model. Radiotherapy Oncol. 2013;108(3):506–10.
Su G, Feng T, Pei T, Yang F, Sun D, Yu H, Wang X, Gao W, He J, Shen Y, et al. Autophagy modulates FSS-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells. Mol Carcinog. 2021;60(9):607–19.
Article CAS PubMed Google Scholar
Ubellacker JM, Tasdogan A, Ramesh V, Shen B. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585(7823):113–8.
Article CAS PubMed PubMed Central Google Scholar
Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, Li B. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Translat Med. 2021;19(1):367.
Shi C, Xie Y, Li X, Li G, Liu W, Pei W, Liu J, Yu X, Liu T. Identification of Ferroptosis-related genes signature predicting the efficiency of invasion and metastasis ability in colon adenocarcinoma. Front Cell Devel Biol. 2021;9: 815104.
Ding Y, Feng Y, Huang Z, Zhang Y, Li X, Liu R, Li H, Wang T, Ding Y, Jia Z, et al. SOX15 transcriptionally increases the function of AOC1 to modulate ferroptosis and progression in prostate cancer. Cell Death Dis. 2022;13(8):673.
Article CAS PubMed PubMed Central Google Scholar
Hsiao YH, Lien HC, Hwa HL, Kuo WH, Chang KJ, Hsieh FJ. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Breast J. 2010;16(3):305–8.
Qu X, Gao D, Ren Q, Jiang X, Bai J, Sheng L. miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC. Oncol Lett. 2018;16(1):853–60.
PubMed PubMed Central Google Scholar
Zou T, Gao Y, Qie M. MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC. Annals Translat Med. 2021;9(2):125.
Shi D, Jiang K, Fu Y, Fang R, Liu XI, Chen J. Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition. Oncol Lett. 2016;11(5):3251–8.
Article CAS PubMed PubMed Central Google Scholar
Yang N, Nijhuis ER, Volders HH, Eijsink JJ, Lendvai A, Zhang B, Hollema H, Schuuring E, Wisman GB, van der Zee AG. Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol. 2010;32(1–2):131–43.
CAS PubMed PubMed Central Google Scholar
Coleman N, Stanley MA. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer. 1994;74(3):884–92.
Article CAS PubMed Google Scholar
Qin R, Cao L, Ye C, Wang J. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma. BMC Med Genomics. 2021;14(1):49.
Article CAS PubMed PubMed Central Google Scholar
Punt S, Houwing-Duistermaat JJ, Schulkens IA, Thijssen VL, Osse EM, de Kroon CD, Griffioen AW, Fleuren GJ, Gorter A, Jordanova ES. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Mol Cancer. 2015;14:71.
Article PubMed PubMed Central Google Scholar
Kayukova EV, Sholokhov LF, Ziganshin AM, Mudrov VA. Inflammatory proteins as molecular markers in the diagnosis of cervical oncopathology. Sovremennye Tekhnologii v Meditsine. 2021;13(4):64–8.
Article CAS PubMed PubMed Central Google Scholar
Liu M, Wei D, Nie Q, Peng L, He L, Cui Y, Ye Y. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes. Taiwan J Obstet Gynecol. 2022;61(4):663–71.
Wang Q, Vattai A, Vilsmaier T. Immunogenomic identification for predicting the prognosis of cervical cancer patients. Int J Mol Sci. 2021;22(5):2442.
Article CAS PubMed PubMed Central Google Scholar
Xu X, Liu T, Wu J, Wang
Comments (0)